• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    3/16/26 9:27:04 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care
    Get the next $QIPT alert in real time by email
    S-8 POS 1 tm268505d2_s8pos.htm S-8 POS

     

    As filed with the Securities and Exchange Commission on March 16, 2026

    Registration No. 333-257940

    Registration No. 333-278648

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    POST-EFFECTIVE AMENDMENT NO. 2 TO:

    FORM S-8 REGISTRATION STATEMENT NO. 333-257940

    POST-EFFECTIVE AMENDMENT NO. 1 TO:

    FORM S-8 REGISTRATION STATEMENT NO. 333-278648

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    Quipt Home Medical Corp.

    (Exact name of registrant as specified in its charter)

     

    British Columbia, Canada N/A
    (State or other jurisdiction of (I.R.S. Employer
    incorporation or organization) Identification Number)
       
    1019 Town Drive  
    Wilder, KY 41076
    (Address of Principal Executive Offices) (Zip Code)

     

    2021 EQUITY INCENTIVE PLAN

    2019 STOCK OPTION PLAN (AS AMENDED)

    2024 EQUITY INCENTIVE PLAN

    (Full title of the plans)

     

    CT Corporation System.
    1015 15th Street N.W., Suite 1000
    Washington, DC 20005

    (Name and address of agent for service)
    (202) 572-3133

    (Telephone number, including area code, of agent for service)

     

    Copies to:

    Larry W. Nishnick
    DLA Piper LLP (US)
    4365 Executive Drive, Suite 1100
    San Diego, CA 92121
    (858) 677-1414

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

      Large accelerated filer ¨ Accelerated filer x
      Non-accelerated filer ¨ Smaller reporting company x
          Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    DEREGISTRATION OF SECURITIES

      

    Quipt Home Medical Corp., a corporation existing under the laws of British Columbia (the “Registrant”), is filing these post-effective amendments (these “Post-Effective Amendments”) to the following registration statements on Form S-8 (together, the “Registration Statements”), which have been previously filed with the Securities and Exchange Commission (the “Commission”), to deregister any and all securities of the Registrant that remain unsold or otherwise unissued under each such Registration Statement as of the date hereof:

     

    ·Registration Statement No. 333-257940 (the “2021 Registration Statement”), filed with the Commission on July 16, 2021, registering an aggregate of 6,126,698 common shares of the Registrant, no par value (“Common Shares”), including (i) up to 2,527,502 Common Shares subject to share options outstanding under the 2019 Stock Option Plan, as amended and restated (the “2019 Plan”) as of July 16, 2021, (ii) up to 2,286,250 Common Shares subject to share options and restricted share unit awards outstanding under the 2021 Equity Incentive Plan (the “2021 Plan”) as of July 16, 2021 and (iii) 1,312,946 Common Shares issuable under the 2021 Plan; as amended by Post-Effective Amendment No.1 filed with the Commission on April 12, 2024, which, in connection with the approval by the Registrant’s security holders of the Registrant’s 2024 Equity Incentive Plan (the “2024 Plan”) to replace the 2021 Plan on March 27, 2024, deregistered (i) those Common Shares previously registered for offer and sale under the 2021 Plan that remained available for grants of new awards under the 2021 Plan immediately prior to its termination (the “Excess Shares”), and (ii) additional Common Shares subject to outstanding awards under the 2021 Plan and the 2019 Plan that expire, are cancelled or are terminated (the “Potential Carry Forward Shares”) upon such forfeiture, cancellation or termination. The 2021 Registration Statement remained in effect as to the 2021 Plan and the 2019 Plan to cover the potential issuance of Common Shares upon the exercise or settlement of the outstanding 2021 Plan awards and the outstanding 2019 Plan awards, as applicable, to which the Potential Carry Forward Shares are subject.

     

    ·Registration Statement No. 333-278648, filed with the Commission on April 12, 2024, registering (i) 3,477,293 Common Shares for issuance under the 2024 Plan, (ii) 482,826 Excess Shares, and (iii) up to 4,460,375 Potential Carry Forward Shares if and when they become eligible for issuance under the terms of the 2024 Plan.

     

    On March 16, 2026, pursuant to an Arrangement Agreement, dated as of December 14, 2025, by and among the Registrant, 1567208 B.C. LTD, a company existing under the laws of British Columbia (“B.C. Purchaser”), and REM Aggregator, LLC, a Delaware limited liability company (collectively with B.C. Purchaser, the “Purchaser”), the Purchaser acquired all of the issued and outstanding Common Shares pursuant to a Plan of Arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”).

     

    As a result of the Arrangement, the Registrant has terminated all offerings of the Registrant’s securities pursuant to its existing registration statements under the Securities Act of 1933, as amended, including the Registration Statements. In accordance with undertakings made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that had been registered for issuance that remain unsold at the termination of the offering, the Registrant hereby removes from registration all of such securities of the Registrant registered but not sold or otherwise issued under the Registration Statements, if any, as of the date hereof. Each Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities, and the Registrant hereby terminates the effectiveness of each Registration Statement.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Wilder, State of Kentucky, on March 16, 2026.

     

    QUIPT HOME MEDICAL CORP.  
         
    By: /s/ Gregory Crawford  
      Gregory Crawford  
      Chief Executive Officer    

     

    Note: No other person is required to sign these Post-Effective Amendments to the Registration Statements in reliance upon Rule 478 under the Securities Act of 1933, as amended.

     

     

     

    Get the next $QIPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QIPT

    DatePrice TargetRatingAnalyst
    5/14/2025$1.70Buy → Hold
    Canaccord Genuity
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    More analyst ratings

    $QIPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

    CINCINNATI, March 16, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company" or "Quipt") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the successful completion of the previously-announced plan of arrangement under the provisions of the Business Corporations Act (British Columbia) (the "Arrangement") in accordance with an arrangement agreement (the "Arrangement Agreement") dated December 14, 2025 among the Company, 1567208 B.C. Ltd. (the "Purchaser") and REM Aggregator, LLC. Pursuant to the Arrangement, and in accordance with the terms of the Arrangement Agreement, the Purchaser, which inclu

    3/16/26 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Receives Final Order Approving Arrangement

    CINCINNATI, March 05, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announces that the Supreme Court of British Columbia issued a final order today in connection with the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") pursuant to which affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC will acquire all of the issued and outstanding common shares of the Company (each, a "Share") for cash consideration of US$3.65 per Share. The final order was the final substan

    3/5/26 8:30:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

    CINCINNATI, March 03, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its special meeting of holders (the "Shareholders") of common shares (the "Shares") of the Company held on March 3, 2026 (the "Meeting") in Sarasota, Florida. The Shareholders voted to approve the special resolution (the "Arrangement Resolution") approving the plan of arrangement under the Business Corporations Act (British Columbia), involving, among other things, the acquisition by affiliates of Kingswood Capital Management, L.P. and Forager Capital Ma

    3/3/26 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quipt Home Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quipt Home Medical from Buy to Hold and set a new price target of $1.70

    5/14/25 8:58:24 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

    5/17/24 7:45:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

    2/16/24 8:29:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:46:40 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:45:41 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:45:08 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.

    SCHEDULE 13D/A - Quipt Home Medical Corp. (0001540013) (Subject)

    3/16/26 1:46:50 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    S-8 POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:27:04 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    S-8 POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:26:27 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Leadership Updates

    Live Leadership Updates

    View All

    Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

    CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

    3/24/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

    CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

    3/28/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces New Independent Board Member

    CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

    2/3/22 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Financials

    Live finance-specific insights

    View All

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-85

    8/11/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Third quarter 2025 financial results on Monday, August 11, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, August 12, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are:  Canada/US Toll Free:1 (833) 752 3722 International:1 (647) 846 8549    A live webcast of the call will be accessible via the investor

    7/29/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care